Clostridium difficile infection (CDI) is the leading cause of antimicrobial and health care-
associated diarrhea in humans, presenting a significant burden to global health care …

Clostridioides difficile (formerly Clostridium difficile) infection is a substantial health and
economic burden worldwide. Great strides have been made over the past several years in …

Clostridium difficile infections (CDIs) are traditionally seen in elderly and hospitalized
patients who have used antibiotic therapy. In the community, CDIs requiring a visit to a …

Clostridium difficile PCR ribotype (RT) 014 is well-established in both human and porcine
populations in Australia, raising the possibility that C. difficile infection (CDI) may have a …

Clostridium difficile is the prominent etiological agent of healthcare-associated diarrhea. The
disease symptoms range from mild diarrhea to life-threatening pseudomembranous colitis …

Clostridium difficile is the largest single cause of hospital-acquired infection in the United
States. A major risk factor for Clostridium difficile infection (CDI) is prior exposure to …

Molecular typing is an essential tool to monitor Clostridium difficile infections and outbreaks
within healthcare facilities. Molecular typing also plays a key role in defining the regional …

The presence and characteristics of Clostridium difficile were investigated in 839 faecal
samples from seven different animal species in the Netherlands. The number of positive …

Over the recent decades, Clostridium difficile infection (CDI) has emerged as a global public
health threat. Despite growing attention, C. difficile remains a poorly understood pathogen …

In this study, intact flagellin proteins were purified from strains of Clostridium difficile and
analyzed using quadrupole time of flight and linear ion trap mass spectrometers. Top-down …